The Global Sacral Nerve Stimulation (SNS) Market is expected to be around $3.3 billion by 2025. The market is primarily driven by factors such as increasing incidence of neurological disorders around the world, rising geriatric population along with increase in the investment for development of sacral nerve stimulation products by the key players in the market. Moreover, increase in the number of patients suffering from overactive bladder (OAB) condition is also expected to largely contribute to the market growth over the forecast period. However, factors such as unfavorable reimbursement policies and side-effects associated with SNS devices can hinder the market growth during the forecast period.
Get an exclusive sample of this report @https://www.crystalmarketresearch.com/report-sample/HC06144
Global Market key players:
Medtronic plc
Nuvectra Corporation
SNS solutions
Axonics Modulation Technologies, Inc,
Medtronic plc,
Nuvectra Corporation
Cogentix Medical.
Nuvectra Corporation
SNS solutions
Axonics Modulation Technologies, Inc,
Medtronic plc,
Nuvectra Corporation
Cogentix Medical.
The sacral nerve stimulator device is implanted under the skin specifically in the upper buttock area. The device consists of an implantable pulse generator. A lead is positioned near the sacral nerve in the lower back through which, a mild electric impulse is delivered which can positively influence the pelvic floor muscles and the rectal sphincters. Before the implantation of the permanent device, patients usually undergo a test to analyze the impact of nerve stimulation in terms of potential response from the patients. The observations from the test are analyzed to determine whether the patient is an appropriate candidate for implanting the permanent device. Implantable SNS devices segment held a significant share of the overall market in 2016 owing to their widespread applications for conditions such as fecal and urine incontinence.
Regional Outlook:
North America held a significant share of the global sacral nerve stimulation market in 2016 owing to large scale adoption of SNS devices to treat patient affected by incontinence. The emerging markets in the Asia-Pacific region are expected to witness favorable growth during the forecast due to the presence of unmet medical needs of the population in the region along with increasing disposable income.
North America held a significant share of the global sacral nerve stimulation market in 2016 owing to large scale adoption of SNS devices to treat patient affected by incontinence. The emerging markets in the Asia-Pacific region are expected to witness favorable growth during the forecast due to the presence of unmet medical needs of the population in the region along with increasing disposable income.
Sacral Nerve Stimulation Market Segmentation:
By Product:
External SNS Devices
Implantable SNS Devices
External SNS Devices
Implantable SNS Devices
By Application:
Urine Incontinence
Fecal Incontinence
Other Applications
Urine Incontinence
Fecal Incontinence
Other Applications
Read More - http://bit.ly/2Gt5Ggr
Comments
Post a Comment